Publications

Il progesterone e il 17α-idrossiprogesterone caproato- a review

Il progesterone (P) c utilizzato in un gran numero di indicazioni terapeutiche quali disordi­ni mestruali, incluse amenorrea secondaria, disordini mestruali premenopausali, supporto della fase luteale, minaccia di aborto, parto pretermine (Carr and Wilson, 1994; Withehead et al., 1990). fl l 7a-idrossiprogesterone, senza esterificazione. non possiede attività progestativa (Junkmann, 1954; Pfiffner and North, 1941) ma i …

More
Myo-Inositol / Publications

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles

 

Objective: To determine the effects of myo-inositol on oocyte quality in polycystic ovary syndrome (PCOS) patients undergoing intracytoplasmic sperm injection (ICSI) cycles. Design: A prospective, controlled, randomized trial. Setting: Assisted reproduction centers. Patient(s): Sixty infertile PCO patients undergoing ovulation induction for ICSI.

Intervention(s): All participants underwent standard long protocol. Starting on the …

More
Myo-Inositol / Publications

Treatment of hirsutism with myo-inositol

The aim of this study was to evaluate the effects of myo-inositol treatment in hirsute women; changes in lipid pattern and insulin sensitivity were also considered. Forty-six hirsute women were enrolled at the first Institute of Obstetrics and Gynecology and evaluated at baseline and after receiving myo-inositol therapy for 6 months. Body mass …

More
Infertility / Myo-Inositol

Odontostomatological approach to pregnant patient

Pregnancy is a condition characterized by various physiological modifications (placentary and ovarian hormones release) that influence various organic districts, including the oral district. In this review were re-examined the rules about the execution of dental services with the relative indications and contraindications during the different phases of pregnancy, the use of the ionizing …

More
Myo-Inositol / Publications

Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction

Background. Polycystic ovary syndrome (PCOS) is often characterized by chronic oligo- or anovulation (usually manifested as oligo- or amenorrhea), and hyperandrogenism. In addition, 30–40% of PCOS women have impaired glucose tolerance, and a defect in the insulin signaling pathway (inositol-containing phosphoglycan mediators) seems to be implicated in the pathogenesis of insulin resistance. PCOS …

More
Publications

The Use of Progesterone in Clinical Practice Evaluation of its Efficacy in Diverse Indications

Introduction: Progesterone is a hormone of paramount importance in the reproductive physiology. Its multiple physiological roles and pharmacology have been extensively studied throughout the years. However, the use of progesterone in the pathophysiology of pregnancy as well as in its other indications remains arguable for diverse reasons. One of these reasons concerns the …

More
Publications

The Use of Progesterone in Clinical Practice: Evaluation of its Efficacy in Diverse Indications Using Different Routes of Administration

 

Introduction: Progesterone is a hormone of paramount importance in the reproductive physiology. Its multiple physiological roles and pharmacology have been extensively studied throughout the years. However, the use of progesterone in the pathophysiology of pregnancy as well as in its other indications remains arguable for diverse reasons. One of these reasons concerns the …

More
Publications

Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study

Objective: To investigate the effects of soy isoflavones on mood and cognitive function in postmenopausal women.

Design: Randomized, double-blind, cross-over, placebo-controlled trial.

Setting: University Hospital, Milan, Italy; A.G.UN.CO. Obstetrics and Gynaecology Centre, Rome, Italy.

Patient(s): Seventy-eight postmenopausal women. Intervention(s): We administered 60 mg/day isoflavones or placebo for 6 months. After a washout period of 1 month, the patients …

More